Friday 6 November 2026 Export RVMD’s income statement to Excel — free account

Revolution Medicines, Inc.

Revolution Medicines, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $11.6 million, down 67.3% from fiscal 2022.

Revenue: +1,188.7%
EPS: −18.0%
Free cash flow: −99.1%
Total debt: +322.7%

Quarter to September 2026, against a year earlier

193.65 16.00 +9.01%

Follow RVMD

Alert me

Market cap: $38.1B
P/E: 0.0×
Fwd P/E: −11.9×
Dividend yield: —
F-score: 4/9
Altman Z: 7.73
Beneish M: −4.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26 From the 10-Q filed 4 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(93.56%)	(79.09%)	(76.67%)	(58.07%)	+8 more TTM periods Free account
ROA Full definition →	(57.07%)	(52.37%)	(59.39%)	(46.06%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(52.90%)	(47.68%)	(80.23%)	(62.23%)
Average Days of Receivables Full definition →	0.00	—	—	—
Free Cash Flow per Share Full definition →	(6.70)	(5.84)	(5.41)	(4.81)
Free Cash Flow Full definition →	(1,440.82)	(1,232.13)	(1,071.73)	(913.73)
Capital Expenditures Full definition →	(9.44)	(9.10)	(14.26)	(15.99)
Other line items
Cash ROIC Full definition →	(23.80%)	(16.25%)	(29.05%)	(23.28%)
Accounts Receivable Turnover Full definition →	0.00	—	—	—
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	693.76%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	119.84%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	(20.62)	(27.42)	(38.07)	(33.61)
Operating CF/Net income Full definition →	0.77	0.69	0.77	0.79
Depreciation/Fixed assets Full definition →	0.00	0.01	(0.12)	(0.34)
Capex/Depreciation Full definition →	0.00	(36.69)	3.69	1.42
Revenue per Share Full definition →	0.97	0.00	0.00	0.00
Operating CF per Share Full definition →	(6.66)	(5.80)	(5.34)	(4.72)
Capex per Share Full definition →	(0.04)	(0.04)	(0.07)	(0.08)
Capex to Sales Full definition →	0.05	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026

Stockrow Weekly